Evidence map›Paper›PMID 32825327›Full record

ReviewBiomolecules2020

Melatonin's Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease.

Diana Maria Chitimus, Mihaela Roxana Popescu, Suzana Elena Voiculescu, Anca Maria Panaitescu, Bogdan Pavel, Leon Zagrean, Ana-Maria Zagrean

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 5 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 5 syntheses or guidelines pooled it, 320 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Diana Maria ChitimusDivision of Physiology and Neuroscience, Department of Functional Sciences, "Carol Davila" University of Medicine and Pharmacy, 010164 Bucharest, Romania.
Mihaela Roxana PopescuDepartment of Cardiology, "Carol Davila" University of Medicine and Pharmacy, Elias University Hospital, 010164 Bucharest, Romania.ORCID 0000-0002-4539-5259
Suzana Elena VoiculescuDivision of Physiology and Neuroscience, Department of Functional Sciences, "Carol Davila" University of Medicine and Pharmacy, 010164 Bucharest, Romania.
Anca Maria PanaitescuDepartment of Obstetrics and Gynecology, "Carol Davila" University of Medicine and Pharmacy, Filantropia Clinical Hospital, 010164 Bucharest, Romania.
Bogdan PavelDivision of Physiology and Neuroscience, Department of Functional Sciences, "Carol Davila" University of Medicine and Pharmacy, 010164 Bucharest, Romania.
Leon ZagreanDivision of Physiology and Neuroscience, Department of Functional Sciences, "Carol Davila" University of Medicine and Pharmacy, 010164 Bucharest, Romania.
Ana-Maria ZagreanDivision of Physiology and Neuroscience, Department of Functional Sciences, "Carol Davila" University of Medicine and Pharmacy, 010164 Bucharest, Romania.ORCID 0000-0002-4302-629X
Carol Davila University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a growing consensus that the antioxidant and anti-inflammatory properties of melatonin are of great importance in preserving the body functions and homeostasis, with great impact in the peripartum period and adult life. Melatonin promotes adaptation through allostasis and stands out as an endogenous, dietary, and therapeutic molecule with important health benefits. The anti-inflammatory and antioxidant effects of melatonin are intertwined and are exerted throughout pregnancy and later during development and aging. Melatonin supplementation during pregnancy can reduce ischemia-induced oxidative damage in the fetal brain, increase offspring survival in inflammatory states, and reduce blood pressure in the adult offspring. In adulthood, disturbances in melatonin production negatively impact the progression of cardiovascular risk factors and promote cardiovascular and neurodegenerative diseases. The most studied cardiovascular effects of melatonin are linked to hypertension and myocardial ischemia/reperfusion injury, while the most promising ones are linked to regaining control of metabolic syndrome components. In addition, there might be an emerging role for melatonin as an adjuvant in treating coronavirus disease 2019 (COVID 19). The present review summarizes and comments on important data regarding the roles exerted by melatonin in homeostasis and oxidative stress and inflammation related pathologies.

Indexed as

Adjuvants, PharmaceuticAnimalsAnti-Inflammatory AgentsAntioxidantsCoronavirus InfectionsCOVID-19HomeostasisHumansMelatoninPandemicsPneumonia, ViralAdjuvants, PharmaceuticAnti-Inflammatory AgentsAntioxidantsMelatoninallostasisantioxidantcardiovascularCOVID 19homeostasismaternal-fetal signalingmelatoninneurodegenerative

Identifiers

PMID32825327
PMCPMC7563541
OpenAlexW3058036789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.